Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
AtriCure
ATRC
$2.51B
| $26.9M | 0.04% |
877,574
+207,472
| +31% | +$6.46M |
|
577
HF Sinclair
DINO
$16.9B
| $26.8M | 0.04% |
524,237
-48,155
| -8% | -$2.95M |
|
|
FDC
578
DELISTED
First Data Corporation
FDC
| $26.8M | 0.04% |
1,583,902
-7,233,956
| -82% | -$141M |
|
|
579
PUT
Starbucks
SBUX
$123B
| $26.7M | 0.04% |
415,000
+240,600
| +138% | +$15.1M |
|
580
Newmont
NEM
$139B
| $26.7M | 0.04% |
771,284
-368,388
| -32% | -$11.9M |
|
581
Pilgrim's Pride
PPC
$7.57B
| $26.5M | 0.04% |
1,710,763
+805,336
| +89% | +$14.4M |
|
|
AZPN
582
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $26.3M | 0.04% |
320,630
-43,054
| -12% | -$3.54M |
|
|
DCPH
583
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $26.2M | 0.04% |
1,246,640
+1,163,815
| +1,405% | +$28.6M |
|
584
Curtiss-Wright
CW
$22.7B
| $26.1M | 0.04% |
255,578
+46,713
| +22% | +$5.22M |
|
585
Willis Towers Watson
WTW
$32.6B
| $26.1M | 0.04% |
171,713
+11,765
| +7% | +$1.76M |
|
|
AMED
586
DELISTED
Amedisys
AMED
| $26.1M | 0.04% |
222,513
+88,634
| +66% | +$10.4M |
|
587
Ally Financial
ALLY
$12.9B
| $26.1M | 0.04% |
1,149,888
+371,947
| +48% | +$9.3M |
|
588
Nasdaq
NDAQ
$55.2B
| $26M | 0.04% |
956,220
+702,984
| +278% | +$20M |
|
589
Schneider National
SNDR
$6.11B
| $25.9M | 0.04% |
1,389,701
+350,953
| +34% | +$7.53M |
|
590
Kosmos Energy
KOS
$1.7B
| $25.8M | 0.04% |
6,338,878
+3,952,349
| +166% | +$24.4M |
|
|
WUBA
591
DELISTED
58.com Inc
WUBA
| $25.8M | 0.04% |
475,851
+157,563
| +50% | +$9.61M |
|
592
Sony
SONY
$142B
| $25.6M | 0.04% |
2,656,120
+451,070
| +20% | +$4.77M |
|
593
Huntsman Corp
HUN
$1.68B
| $25.6M | 0.04% |
1,328,464
-945,574
| -42% | -$20.3M |
|
|
CTXS
594
CALL
DELISTED
Citrix Systems Inc
CTXS
| $25.6M | 0.04% |
+250,000
| New | +$26.4M |
|
595
PUT
Booking.com
BKNG
$160B
| $25.5M | 0.04% |
370,000
-275,000
| -43% | -$20.2M |
|
|
EA
596
PUT
DELISTED
Electronic Arts
EA
| $25.5M | 0.04% |
322,800
+198,200
| +159% | +$18.2M |
|
597
Lamar Advertising Co
LAMR
$15.5B
| $25.2M | 0.04% |
364,903
+236,151
| +183% | +$17.4M |
|
598
Under Armour
UAA
$2.31B
| $25.2M | 0.04% |
1,428,073
+883,893
| +162% | +$18.1M |
|
|
EV
599
DELISTED
Eaton Vance Corp.
EV
| $25.2M | 0.04% |
715,980
-128,006
| -15% | -$5.41M |
|
|
SF
600
Stifel
SF
$12.2B
| $25.2M | 0.04% |
1,367,066
-923,871
| -40% | -$19.1M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.